Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
Verified

What's the purpose of this trial?

This is a Phase 1 study to evaluate the safety, pharmacokinetics(PK), and preliminary clinical activity of KPG-818 as a single agent in adult subjects with selected hematological malignancies, including multiple myeloma (MM), mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), indolent lymphoma, adult T-cell leukemia-lymphoma (ATL), or chronic lymphocytic leukemia (CLL).

This trial is currently open and accepting patients.


What will happen during the trial?

This study will assist in identifying appropriate, well tolerated doses that can be administered in subsequent studies in subjects with selected hematological malignancies.

Additional Trial Information

Phase 1

Enrollment: 56 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

California

University of California Davis Comprehensive Cancer Center

Sacramento, CA

Open and Accepting

Florida

Boca Raton Clinical Research (BRCR) Medical Center

Plantation, FL

Open and Accepting

Kentucky

Norton Cancer Institute St. Matthews Campus

Louisville, KY

Open and Accepting

New York

New York Cancer and Blood Specialists

Bronx, NY

Open and Accepting

New York Cancer and Blood Specialists

East Patchogue, NY

Open and Accepting

New York Cancer and Blood Specialists

New York, NY

Open and Accepting

North Shore Hematology Oncology Associates, PC

Port Jefferson Station, NY

Open and Accepting

New York Cancer and Blood Specialists

Port Jefferson Station, NY

Open and Accepting

New York Cancer and Blood Specialists

Riverhead, NY

Open and Accepting

Oregon

Providence Portland Medical Center

Portland, OR

Open and Accepting

Wisconsin

Medical College of Wisconsin Froedtert Hospital

Milwaukee, WI

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message

SparkCures Verified

SparkCures is working closely with Kangpu Biopharmaceuticals, Ltd. to provide the most up-to-date information on this clinical trial. Use the button above to add this trial to your list of favorites.

Learn more about how we work with trial sponsors